BioXcellerator
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19 (NCT04390152) | BioXcellerator | 2020-01-13 |
Track BioXcellerator automatically
Every clearance here is in the API, with alerts when new ones post.